|
|
Volumn 30, Issue 5, 1998, Pages 2185-2188
|
|
Rapamycin: Personal algorithms for use based on 250 treated renal allograft recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
HUMAN;
HYPERLIPIDEMIA;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LYMPHADENOPATHY;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT INDICATION;
ALGORITHMS;
CLINICAL TRIALS;
CYCLOSPORINE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
POLYENES;
SIROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0031710186
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00585-5 Document Type: Conference Paper |
|
Times cited : (34)
|
|
References (16)
|
